• ClipSaver
ClipSaver
Русские видео
  • Смешные видео
  • Приколы
  • Обзоры
  • Новости
  • Тесты
  • Спорт
  • Любовь
  • Музыка
  • Разное
Сейчас в тренде
  • Фейгин лайф
  • Три кота
  • Самвел адамян
  • А4 ютуб
  • скачать бит
  • гитара с нуля
Иностранные видео
  • Funny Babies
  • Funny Sports
  • Funny Animals
  • Funny Pranks
  • Funny Magic
  • Funny Vines
  • Funny Virals
  • Funny K-Pop
По дате По просмотрам Рейтинг
Последние добавленные видео:

T315I-mutation

  • Debate: Chronic-Phase CML Patient Develops a T315I Mutation - Experimental Therapy 6 лет назад

    Debate: Chronic-Phase CML Patient Develops a T315I Mutation - Experimental Therapy

    1718 6 лет назад 17:31
  • Ponatinib Efficacy and Safety With the T315I Mutation: Long-Term Follow-up of Phase 1&2 Trials 10 лет назад

    Ponatinib Efficacy and Safety With the T315I Mutation: Long-Term Follow-up of Phase 1&2 Trials

    160 10 лет назад 4:18
  • Debate: Chronic-Phase CML Patient Develops a T315I Mutation - Transplant 6 лет назад

    Debate: Chronic-Phase CML Patient Develops a T315I Mutation - Transplant

    1143 6 лет назад 17:38
  • Post hoc analysis of OPTIC: patient responses by T315I mutation status 2 года назад

    Post hoc analysis of OPTIC: patient responses by T315I mutation status

    66 2 года назад 1:32
  • Case 2: Additional Treatment Considerations for T315I-Mutated CML 6 лет назад

    Case 2: Additional Treatment Considerations for T315I-Mutated CML

    235 6 лет назад 5:31
  • Case 2: Ponatinib for T315I-Mutated CML 6 лет назад

    Case 2: Ponatinib for T315I-Mutated CML

    458 6 лет назад 5:07
  • Phase I study of asciminib in patients with CP-CML carrying the T315I mutation 2 года назад

    Phase I study of asciminib in patients with CP-CML carrying the T315I mutation

    553 2 года назад 1:03
  • Dr Deininger on Long-Term Outcomes With Ponatinib in T315I-Mutant CP-CML 1 год назад

    Dr Deininger on Long-Term Outcomes With Ponatinib in T315I-Mutant CP-CML

    78 1 год назад 2:32
  • First-in-class STAMP inhibitor asciminib in patients with CML harbouring the T315I mutation 4 года назад

    First-in-class STAMP inhibitor asciminib in patients with CML harbouring the T315I mutation

    594 4 года назад 7:30
  • CHRONIC MYELOID LEUKEMIA: RESISTANT / INTOLERANT AND T315I MUTANT: PART 1 @iam_haematology_oncology 2 года назад

    CHRONIC MYELOID LEUKEMIA: RESISTANT / INTOLERANT AND T315I MUTANT: PART 1 @iam_haematology_oncology

    90 2 года назад 9:33
  • What are the sensitivities of different CML therapies to various mutations including T315I? 9 лет назад

    What are the sensitivities of different CML therapies to various mutations including T315I?

    132 9 лет назад 4:15
  • Expert Cancer Panel: CML chronic phase T315I mutated s/p multiple lines of therapy 5 месяцев назад

    Expert Cancer Panel: CML chronic phase T315I mutated s/p multiple lines of therapy

    16 5 месяцев назад 10:27
  • ENLIVEN 01’s Role in Addressing Quality of Life and Mutation Challenges in CML – Dr. Andreas Hochhau 2 недели назад

    ENLIVEN 01’s Role in Addressing Quality of Life and Mutation Challenges in CML – Dr. Andreas Hochhau

    0 2 недели назад 3:19
  • Post-hoc analysis of OPTIC: patient responses to ponatinib by T315I mutational status 1 год назад

    Post-hoc analysis of OPTIC: patient responses to ponatinib by T315I mutational status

    98 1 год назад 1:57
  • The Future of CML Care: From TKIs to Treatment-Free Remission ft. Dr. Andreas Hochhaus 1 месяц назад

    The Future of CML Care: From TKIs to Treatment-Free Remission ft. Dr. Andreas Hochhaus

    6 1 месяц назад 31:26
  • Addressing the issue of resistance to TKIs in CML 2 года назад

    Addressing the issue of resistance to TKIs in CML

    98 2 года назад 2:11
  • Genomics & Mutations in CML - Risk & Assessment 2 года назад

    Genomics & Mutations in CML - Risk & Assessment

    314 2 года назад 46:08
  • Resistance to Targeted-TKI Treatment in Patients With CML 6 лет назад

    Resistance to Targeted-TKI Treatment in Patients With CML

    519 6 лет назад 6:51
  • OPTIC: Ponatinib in chronic-phase CML 3 года назад

    OPTIC: Ponatinib in chronic-phase CML

    325 3 года назад 1:37
Следующая страница»

Контактный email для правообладателей: [email protected] © 2017 - 2025

Отказ от ответственности - Disclaimer Правообладателям - DMCA Условия использования сайта - TOS



Карта сайта 1 Карта сайта 2 Карта сайта 3 Карта сайта 4 Карта сайта 5